NCT02020187

Brief Summary

Congenital myopathies are clinical and genetic heterogeneous disorders characterized by skeletal muscle weakness. Most patients experience muscle weakness and fatigue throughout their life. However, progression of symptoms is rare. There are no specific treatments for congenital myopathies. Training has been shown to benefit several other muscle diseases with weakness, but the defect in congenital myopathies involves contractile proteins of the sarcomere, why the effect of training is uncertain in these conditions. The investigators will therefore investigate the effect cycle-ergometer training for 30 minutes, three times weakly, for ten weeks in 15 patients with congenital myopathy. Another 5-10 congenital myopathy patients, who do not train, will serve as controls for the trained patients. The study starts and ends with a test day, where efficacy based on VO2max, performance in functional tests and a questionnaire will be assessed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

November 28, 2013

Completed
26 days until next milestone

First Posted

Study publicly available on registry

December 24, 2013

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
Last Updated

May 12, 2015

Status Verified

May 1, 2015

Enrollment Period

1.2 years

First QC Date

November 28, 2013

Last Update Submit

May 11, 2015

Conditions

Keywords

Congenital myopathyExercise

Outcome Measures

Primary Outcomes (1)

  • Efficacy based on VO2,max

    Difference in VO2,max from baseline to end of intervention.

    10 weeks

Secondary Outcomes (7)

  • Level of Creatine Kinase

    10 weeks

  • Intensity in maximal Watt

    10 weeks

  • 6 minute walk test

    10 weeks

  • SF-36 questionnaire

    10 weeks

  • A timed five-repetitions-sit-to-stand-test

    10 weeks

  • +2 more secondary outcomes

Study Arms (2)

Exercise

EXPERIMENTAL

10 weeks of home training on a cycle-ergometer. Exercise 30 minutes every other day or at least three times a week.

Other: Exercise on a cycle-ergometer

Controls

NO INTERVENTION

Controls with diagnosed congenital myopathy. Subjects are tested two times on a cycle ergometer. There will be ten weeks between the tests. In between tests the subjects are living life as usual without any interventions.

Interventions

Home training on an ergometer-cycle 30 minutes every other day or at least three times a week. Subject will exercise in a pulse interval corresponding to 70% of their maximal VO2.

Exercise

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Danish patients with gene verified congenital myopathy

You may not qualify if:

  • Patients who are to week to train at a cycle-ergometer for 10 weeks
  • Patients who have other health issues, which can disturb the interpretation of the efficacy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Neuromuscular Research Unit

Copenhagen, 2100, Denmark

Location

Related Publications (1)

  • Hedermann G, Vissing CR, Heje K, Preisler N, Witting N, Vissing J. Aerobic Training in Patients with Congenital Myopathy. PLoS One. 2016 Jan 11;11(1):e0146036. doi: 10.1371/journal.pone.0146036. eCollection 2016.

MeSH Terms

Conditions

Myotonia CongenitaMotor Activity

Condition Hierarchy (Ancestors)

Myotonic DisordersMuscular DiseasesMusculoskeletal DiseasesHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesNervous System DiseasesNeuromuscular DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesBehavior

Study Officials

  • Gitte H Pedersen, Bsc Medicine

    Rigshospitalet, Denmark

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical student, Bsc

Study Record Dates

First Submitted

November 28, 2013

First Posted

December 24, 2013

Study Start

September 1, 2013

Primary Completion

November 1, 2014

Study Completion

November 1, 2014

Last Updated

May 12, 2015

Record last verified: 2015-05

Locations